{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:26:54Z","timestamp":1789244814357,"version":"build-2803163510"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,26]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Primary biliary cholangitis (PBC) is characterized as interlobular bile duct injury and fibrosis, which results from the loss of tolerance to self-antigens. However, the exact pathologic mechanism leading to injury and fibrosis in PBC patients is not fully understood. Therefore, in this study, we examined the role of the T cell\u00a0subsets\u00a0in PBC patients and healthy controls (HCs). A higher number of invariant Natual killer T (iNKT) cells as well as CD3+CD56+ \u03b1Galcer-CD1d tetramer\u2013 T cells were found in patients with PBC compared with HCs. Moreover, these 2 T subpopulations produced significantly higher levels of Interleukin (IL)-17A in PBC patients than those in in HCs, which has also been positively correlated with the disease severity. Furthermore, the level of IL-17A produced by these 2 subpopulations was increased after stimulation of the autoantibodies in patients with PBC. Also, the elevated IL-17A levels promoted the PBC-related fibrosis, thus presenting a change in frequencies and functions of these cell phenotypes in the deterioration of the duct damage-related fibrosis. This study clarified PBC patients\u2019 distinct T subpopulations characteristics, providing evidence-based diagnostic and therapies for these patients. The correlation between unclassical T subsets and IL-17A may provide a novel target for the immunotherapy of PBC.<\/jats:p>","DOI":"10.1002\/jlb.2a0622-586rrrr","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T12:09:02Z","timestamp":1655899742000},"page":"1079-1087","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["IL-17A produced by invariant natural killer T cells and CD3+CD56+\u03b1Galcer-CD1d tetramer\u2013 T cells promote liver fibrosis in patients with primary biliary cholangitis"],"prefix":"10.1093","volume":"112","author":[{"given":"Hongyu","family":"Jia","sequence":"first","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujun","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefan","family":"Bi","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hetong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Mental Health, The First Affiliated Hospital, College of Medicine, Zhejiang University , Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Toronto , Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Xu","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Diao","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,22]]},"reference":[{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-0034-1383729","article-title":"Breach of tolerance: primary biliary cirrhosis","volume":"34","author":"Wang","year":"2014","journal-title":"Semin Liver Dis"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/liv.14066","article-title":"TCRbeta repertoire of memory T cell reveals potential role for Escherichia coli in the pathogenesis of primary biliary cholangitis","volume":"39","author":"Hou","year":"2019","journal-title":"Liver Int"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.autrev.2014.01.041","article-title":"The diagnosis of primary biliary cirrhosis","volume":"13","author":"Bowlus","year":"2014","journal-title":"Autoimmunity Reviews"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"108406","DOI":"10.18632\/oncotarget.22658","article-title":"Regulatory T cells with a defect in inhibition on co-stimulation deteriorated primary biliary cholangitis","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/med.21276","article-title":"Raising the roof: the preferential pharmacological stimulation of Th1 and th2 responses mediated by NKT cells","volume":"34","author":"East","year":"2014","journal-title":"Med Res Rev"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.24113","article-title":"Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis","volume":"53","author":"Wu","year":"2011","journal-title":"Hepatology"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1002\/hep.21060","article-title":"The liver as an immunological organ","volume":"43","author":"Racanelli","year":"2006","journal-title":"Hepatology"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23983","article-title":"Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells","volume":"53","author":"Jin","year":"2011","journal-title":"Hepatology"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"8988","DOI":"10.1002\/jcp.27571","article-title":"Thrombin cleavage of osteopontin controls activation of hepatic stellate cells and is essential for liver fibrogenesis","volume":"234","author":"Cui","year":"2019","journal-title":"J Cell Physiol"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.imlet.2014.03.013","article-title":"A possible role for NKT-like cells in patients with chronic hepatitis B during telbivudine treatment","volume":"160","author":"Diao","year":"2014","journal-title":"Immunology Letters"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.immuni.2004.08.012","article-title":"Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases","volume":"21","author":"Diao","year":"2004","journal-title":"Immunity"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaut.2008.11.001","article-title":"Hepatic IL-17 responses in human and murine primary biliary cirrhosis","volume":"32","author":"Lan","year":"2009","journal-title":"J Autoimmun"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1478-3231.2009.02051.x","article-title":"Primary biliary cirrhosis, bacteria and molecular mimicry: what's the molecule and where's the mimic?","volume":"29","author":"Wasilenko","year":"2009","journal-title":"Liver Int"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/hep.26979","article-title":"IL-12\/Th1 and IL-23\/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"102328","DOI":"10.1016\/j.jaut.2019.102328","article-title":"The challenges of primary biliary cholangitis: what is new and what needs to be done","volume":"105","author":"Terziroli Beretta-Piccoli","year":"2019","journal-title":"J Autoimmun"},{"key":"2023032107472658400_","volume-title":"NLRP3 inflammasome driven liver injury and fibrosis: roles of IL-17 and TNF in mice","author":"Wree"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0034-1383731","article-title":"The natural history of primary biliary cirrhosis","volume":"34","author":"Imam","year":"2014","journal-title":"Semin Liver Dis"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12016-015-8516-5","article-title":"The natural history and prognosis of primary biliary cirrhosis with clinical features of autoimmune hepatitis","volume":"50","author":"Yang","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1053\/gast.2002.36020","article-title":"Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer","volume":"123","author":"Kita","year":"2002","journal-title":"Gastroenterology"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1034\/j.1600-0676.2003.00807.x","article-title":"Accumulating CD57 + CD3 + natural killer T cells are related to intrahepatic bile duct lesions in primary biliary cirrhosis","volume":"23","author":"Harada","year":"2003","journal-title":"Liver Int"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.autrev.2011.06.003","article-title":"Role of NKT cells in autoimmune liver disease","volume":"10","author":"Santodomingo-Garzon","year":"2011","journal-title":"Autoimmun Rev"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaut.2013.06.013","article-title":"Mucosal immunity in liver autoimmunity: a comprehensive review","volume":"46","author":"Trivedi","year":"2013","journal-title":"J Autoimmun"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaut.2014.02.009","article-title":"Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2Ralpha(-\/-) mice","volume":"51","author":"Yao","year":"2014","journal-title":"J Autoimmun"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0168-8278(98)80206-7","article-title":"Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes","volume":"28","author":"Norris","year":"1998","journal-title":"J Hepatol"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2015.08.020","article-title":"Immunity, tolerance and autoimmunity in the liver: a comprehensive review","volume":"66","author":"Doherty","year":"2016","journal-title":"J Autoimmun"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"262A","DOI":"10.1002\/hep.21385","article-title":"IL-2 receptor alpha-\/- mice and the development of primary biliary cirrhosis","volume":"44","author":"Wakabayashi","year":"2006","journal-title":"Hepatology"},{"key":"2023032107472658400_","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1053\/j.gastro.2011.03.009","article-title":"Interleukin-12 converts Foxp3+ regulatory T cells to interferon-gamma-producing Foxp3+ T cells that inhibit colitis","volume":"140","author":"Feng","year":"2011","journal-title":"Gastroenterology"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/JLB.2A0622-586RRRR","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/JLB.2A0622-586RRRR","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/112\/5\/1079\/49470650\/jlb11183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/112\/5\/1079\/49470650\/jlb11183.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T15:09:25Z","timestamp":1700752165000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/112\/5\/1079\/6976274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,22]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,6,22]]},"published-print":{"date-parts":[[2022,10,26]]}},"URL":"https:\/\/doi.org\/10.1002\/jlb.2a0622-586rrrr","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11]]},"published":{"date-parts":[[2022,6,22]]},"assertion":[{"value":"2020-09-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}